Pathogenetics of the RASopathies

Overview

Journal Hum Mol Genet

Specialties Genetics
Molecular Biology

Date 2016 Jul 15

PMID 27412009

Citations 60

Authors

William E Tidyman

Katherine A Rauen

Affiliations

Soon will be listed here.

Abstract

The RASopathies are defined as a group of medical genetics syndromes that are caused by germ-line mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway. Taken together, the RASopathies represent one of the most prevalent groups of malformation syndromes affecting greater than 1 in 1,000 individuals. The Ras/MAPK pathway has been well studied in the context of cancer as it plays essential roles in growth, differentiation, cell cycle, senescence and apoptosis, all of which are also critical to normal development. The consequence of germ-line dysregulation leads to phenotypic alterations of development. RASopathies can be caused by several pathogenetic mechanisms that ultimately impact or alter the normal function and regulation of the MAPK pathway. These pathogenetic mechanisms can include functional alteration of GTPases, Ras GTPase-activating proteins, Ras guanine exchange factors, kinases, scaffolding or adaptor proteins, ubiquitin ligases, phosphatases and pathway inhibitors. Although these mechanisms are diverse, the common underlying biochemical phenotype shared by all the RASopathies is Ras/MAPK pathway activation. This results in the overlapping phenotypic features among these syndromes.

Citing Articles

Insights in biomarkers complexity and routine clinical practice for the diagnosis of thyroid nodules and cancer.

de Matos M, Pinto M, Goncalves A, Canberk S, Bugalho M, Soares P PeerJ. 2025; 13():e18801.

PMID: 39850836 PMC: 11756370. DOI: 10.7717/peerj.18801.

ERK activation dynamics in maturing oocyte controls embryonic nuclear divisions in Caenorhabditis elegans.

Baek H, Das D, Chen S, Li H, Arur S Cell Rep. 2025; 44(1):115157.

PMID: 39792558 PMC: 11874628. DOI: 10.1016/j.celrep.2024.115157.

Pigment epithelium derived factor drives melanocyte proliferation and migration in neurofibromatosis café au lait macules.

Lovatt C, Williams M, Gibbs A, Mukhtar A, Morgan H, Lanfredini S Skin Health Dis. 2024; 4(5):e394.

PMID: 39355740 PMC: 11442068. DOI: 10.1002/ski2.394.

Impact of pathogenic variants of the Ras-mitogen-activated protein kinase pathway on major white matter tracts in the human brain.

Siqueiros-Sanchez M, Dai E, McGhee C, McNab J, Raman M, Green T Brain Commun. 2024; 6(4):fcae274.

PMID: 39210910 PMC: 11358645. DOI: 10.1093/braincomms/fcae274.

RASopathies - what they reveal about RAS/MAPK signaling in skeletal muscle development.

Rauen K, Tidyman W Dis Model Mech. 2024; 17(6).

PMID: 38847227 PMC: 11179721. DOI: 10.1242/dmm.050609.

References

Wang D, Hammond V, Abud H, Bertoncello I, McAvoy J, Bowtell D . Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development. Genes Dev. 1997; 11(3):309-20. DOI: 10.1101/gad.11.3.309. View

Chen P, Yin J, Yu H, Yuan T, Fernandez M, Yung C . Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci U S A. 2014; 111(31):11473-8. PMC: 4128129. DOI: 10.1073/pnas.1324128111. View

Arafeh R, Qutob N, Emmanuel R, Keren-Paz A, Madore J, Elkahloun A . Recurrent inactivating RASA2 mutations in melanoma. Nat Genet. 2015; 47(12):1408-10. PMC: 4954601. DOI: 10.1038/ng.3427. View

Yoon S, Seger R . The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006; 24(1):21-44. DOI: 10.1080/02699050500284218. View

Schubbert S, Zenker M, Rowe S, Boll S, Klein C, Bollag G . Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006; 38(3):331-6. DOI: 10.1038/ng1748. View

Viskochil D, Buchberg A, Xu G, Cawthon R, Stevens J, Wolff R . Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990; 62(1):187-92. DOI: 10.1016/0092-8674(90)90252-a. View

van Trier D, van Nierop J, Draaisma J, van der Burgt I, Kunst H, Croonen E . External ear anomalies and hearing impairment in Noonan Syndrome. Int J Pediatr Otorhinolaryngol. 2015; 79(6):874-878. DOI: 10.1016/j.ijporl.2015.03.021. View

Craig J, Mikhailenko I, Noyes N, Migliorini M, Strickland D . The LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events. PLoS One. 2013; 8(7):e70432. PMC: 3724782. DOI: 10.1371/journal.pone.0070432. View

McGrath J, Capon D, Goeddel D, Levinson A . Comparative biochemical properties of normal and activated human ras p21 protein. Nature. 1984; 310(5979):644-9. DOI: 10.1038/310644a0. View

10.

Esteban L, Fernandez-Medarde A, Lopez E, Yienger K, Guerrero C, Ward J . Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development. Mol Cell Biol. 2000; 20(17):6410-3. PMC: 86116. DOI: 10.1128/MCB.20.17.6410-6413.2000. View

11.

Digilio M, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B . Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet. 2002; 71(2):389-94. PMC: 379170. DOI: 10.1086/341528. View

12.

Alessandrini A, Brott B, Erikson R . Differential expression of MEK1 and MEK2 during mouse development. Cell Growth Differ. 1997; 8(5):505-11. View

13.

Stowe I, Mercado E, Stowe T, Bell E, Oses-Prieto J, Hernandez H . A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1. Genes Dev. 2012; 26(13):1421-6. PMC: 3403010. DOI: 10.1101/gad.190876.112. View

14.

Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R . Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007; 39(9):1120-6. DOI: 10.1038/ng2113. View

15.

Kraft M, Cirstea I, Voss A, Thomas T, Goehring I, Sheikh B . Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice. J Clin Invest. 2011; 121(9):3479-91. PMC: 3163944. DOI: 10.1172/JCI43428. View

16.

Anastasaki C, Estep A, Marais R, Rauen K, Patton E . Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Hum Mol Genet. 2009; 18(14):2543-54. PMC: 2701326. DOI: 10.1093/hmg/ddp186. View

17.

Niemeyer C, Kang M, Shin D, Furlan I, Erlacher M, Bunin N . Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet. 2010; 42(9):794-800. PMC: 4297285. DOI: 10.1038/ng.641. View

18.

Piotrowski A, Xie J, Liu Y, Poplawski A, Gomes A, Madanecki P . Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet. 2013; 46(2):182-7. PMC: 4352302. DOI: 10.1038/ng.2855. View

19.

Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F . Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet. 2010; 87(2):250-7. PMC: 2917705. DOI: 10.1016/j.ajhg.2010.06.015. View

20.

Wu J, Harrison J, Dent P, Lynch K, Weber M, Sturgill T . Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol Cell Biol. 1993; 13(8):4539-48. PMC: 360070. DOI: 10.1128/mcb.13.8.4539-4548.1993. View